| |
| |
|
| Insider
Information: |
Welch Daniel G |
| Relationship: |
|
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
681,552 |
|
|
Indirect Shares
|
123,508 |
|
|
| Direct
Value |
$7,743,872 |
|
|
|
Indirect Value
|
$4,223,974 |
|
|
| Total
Shares |
805,060 |
|
|
| Total
Value |
$11,967,846 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -4.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
InterMune Inc |
ITMN |
Chairman, CEO and Pres... |
2014-09-29 |
0 |
2004-08-12 |
0 |
Premium* |
|
|
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2023-12-14 |
0 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
Director |
2015-05-07 |
0 |
2014-05-27 |
0 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
Director |
2023-06-07 |
21,605 |
2016-06-09 |
0 |
Premium* |
|
|
Avexis, Inc. |
AVXS |
Director |
2018-05-15 |
0 |
2018-03-13 |
0 |
Premium* |
|
|
Structure Therapeutics Inc. |
GPCR |
Director |
2023-02-07 |
0 |
2023-02-07 |
123,508 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
|
2024-05-24 |
659,947 |
2024-05-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
127 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
Director |
– • – |
2014-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
13,119 |
0 |
- |
|
| ITMN |
InterMune Inc |
Charman, CEO and President |
• • – |
2014-05-19 |
4 |
AS |
$38.00 |
$441,066 |
D/D |
(11,607) |
93,931 |
0 |
- |
|
| ITMN |
InterMune Inc |
Charman, CEO and President |
• • – |
2014-05-19 |
4 |
OE |
$15.34 |
$178,051 |
D/D |
11,607 |
105,538 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-05-23 |
4 |
OE |
$8.73 |
$364,655 |
D/D |
34,544 |
128,475 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-05-23 |
4 |
AS |
$40.01 |
$1,381,974 |
D/D |
(34,544) |
93,931 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-05-27 |
4 |
OE |
$15.34 |
$106,987 |
D/D |
6,949 |
100,880 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-05-27 |
4 |
AS |
$40.15 |
$278,970 |
D/D |
(6,949) |
93,931 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
Director |
– • – |
2014-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,617 |
2,617 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-05-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,750 |
102,681 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-05-30 |
4 |
S |
$40.06 |
$182,894 |
D/D |
(4,565) |
98,116 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-06-04 |
4 |
S |
$39.19 |
$153,401 |
D/D |
(3,914) |
94,202 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-06-16 |
4 |
AS |
$45.02 |
$675,252 |
D/D |
(15,000) |
94,202 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-06-16 |
4 |
OE |
$19.01 |
$285,150 |
D/D |
15,000 |
109,202 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-08-05 |
4 |
AS |
$44.95 |
$6,568,684 |
D/D |
(146,125) |
94,202 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-08-05 |
4 |
OE |
$8.73 |
$1,304,476 |
D/D |
146,125 |
240,327 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-08-07 |
4 |
AS |
$45.17 |
$1,124,813 |
D/D |
(24,900) |
94,202 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-08-07 |
4 |
OE |
$8.73 |
$217,377 |
D/D |
24,900 |
119,102 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-09-29 |
4 |
D |
$74.00 |
$1,702,000 |
D/D |
(23,000) |
0 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-09-29 |
4 |
D |
$74.00 |
$5,268,948 |
D/D |
(71,202) |
23,000 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
Director |
– • – |
2015-05-07 |
4 |
D |
$46.00 |
$120,382 |
D/D |
(2,617) |
0 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2015-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
16,819 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2016-03-08 |
4 |
OE |
$9.82 |
$245,500 |
D/D |
25,000 |
41,819 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2016-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
45,519 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
|
– • – |
2016-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,875 |
1,875 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2017-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
49,219 |
0 |
- |
|
127 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
